Harriette Van Spall

Harriette Van Spall

Associate Professor of Medicine, Director of E-Health and Virtual Care

MD

McMaster University, Hamilton, CA

  • Twitter
  • OrcidID

Biography

Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.

She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.

Dr Van Spall is an Editorial Board member of Cardiac Failure Review.

Read more

Media

HFA 23: Trientine-HCL for Treatment of HFrEF

James L Januzzi, Harriette Van Spall,

Watch time: 4m 3s
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Harriette Van Spall, James L Januzzi,

Watch time: 13m 32s

Jasper J Brugts, Ahmad Masri , Marianna Fontana, et al

Watch time: 1h 42m 27s (14 videos)
HFA 23 Late-Breaker Discussion: Hospital to Home in Heart Failure

Harriette Van Spall, Tariq Ahmad, Jozine ter Maaten, et al

Watch time: 26m 30s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall,

Watch time: 5m 48s
ACC.23 Late-Breaker Discussion: The BIOVASC Trial

Harriette Van Spall, Roberto Diletti,

Watch time: 12m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
ACC 23 Late-breaker Discussion: The BETTER-CARE HF Trial

Harriette Van Spall, Amrita Mukhopadhyay,

Watch time: 14m 3s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
ACC 23 Late-breaker Discussion: The REVIVED-BCIS2 Viability Study

Harriette Van Spall, Divaka Perera, Peter O’Kane, et al

Watch time: 16m 24s

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 24m 42s (10 videos)
AHA 22 Late-Breaker Discussion: The DCP Trial

Areef Ishani, Harriette Van Spall,

Watch time: 13m 40s
AHA 22: Late-Breaker Discussion: The STRONG-HF Trial

Alexandre Mebazaa, Harriette Van Spall,

Watch time: 21m 14s
AHA 22 Late-Breaker Discussion: The PRECISE Trial

Pamela S Douglas, Harriette Van Spall,

Watch time: 14m 56s
AHA 22: Late-Breaker Discussion: The TRANSFORM-HF Trial

Harriette Van Spall, Robert Mentz,

Watch time: 13m 29s
ESC 22 Late-breaker Discussion: The ADVOR Trial

Harriette Van Spall, Wilfried Mullens,

Watch time: 11m 5s
ESC 22 Late-breaker Discussion: The REVIVED Trial

Divaka Perera, Harriette Van Spall,

Watch time: 14m 31s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s
ESC 22 Late-breaker Discussion: The DELIVER Trial

Harriette Van Spall, Scott Solomon,

Watch time: 11m 27s
Masterclass: Evidence on the Use of SGLT2is in HF Across the EF Spectrum

Scott Solomon, Harriette Van Spall, Mikhail Kosiborod, et al

Watch time: 29m 37s

Shelley Zieroth, Andrew JS Coats, Javed Butler, et al

Watch time: 10h 52m 24s (14 videos)
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s
ACC/AHA/HFSA Guideline for the Management of Heart Failure

Mikhail Kosiborod, Harriette Van Spall,

Watch time: 3m 14s

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)
ACC 22 Late-breaker Discussion: The PROMPT-HF Trial

Gregg C Fonarow, Tariq Ahmad, Harriette Van Spall, et al

Watch time: 15m 38s
ACC 2022 Late-breaker Discussion: The SODIUM-HF Trial

Justin Ezekowitz, Harriette Van Spall,

Watch time: 16m 42s
ACC 2022 Late-breaker Discussion: The SuperWIN Trial

Dylan L Steen, Harriette Van Spall,

Watch time: 16m 57s
A Masterclass on Building a Legacy With Dr. Milton Packer

Milton Packer, Harriette Van Spall,

Watch time: 56m (7 videos)
Masterclass on Building A Legacy With Dr. Milton Packer

Milton Packer, Harriette Van Spall,

Watch time: 55m 12s
AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study

Harriette Van Spall, Alexander J Blood,

Watch time: 12m 12s
AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial

Harriette Van Spall, John Spertus,

Watch time: 16m 2s
AHA 2021 Late-breaker Discussion: The EMPULSE Trial

Harriette Van Spall, Adriaan A Voors,

Watch time: 16m 38s
ESC 2021 Discussion: The EMPEROR-Pooled Study

Milton Packer, Harriette Van Spall,

Watch time: 20m 8s
Masterclass on The Global Burden of CV Disease in Women

Birgit Vogel, Harriette Van Spall,

Watch time: 20m 32s
ESC 2021 Discussion: The FIGARO-DKD Trial

Bertram Pitt, Harriette Van Spall,

Watch time: 15m 2s
ESC 2021 Discussion: The EMPEROR-Preserved Trial

Stefan Anker, Harriette Van Spall,

Watch time: 19m 47s
ESC HF 21 Discussion: Vericiguat in Patients with AFIB and HF with HFrEF

Harriette Van Spall, Piotr Ponikowski,

Watch time: 17m 14s
Masterclass on Achievement in the Face of Adversity with Dr Eugene Braunwald

Eugene Braunwald, Harriette Van Spall,

Watch time: 23m 47s
Masterclass: Neprilysin Inhibition in Patients with reduced LVEF

Eugene Braunwald, Harriette Van Spall,

Watch time: 27m 37s
ACC 2021 Discussion: The STRENGTH Study

Steven E Nissen, Harriette Van Spall,

Watch time: 9m 1s
ACC 2021 Discussion: The LIFE Trial

Harriette Van Spall, Douglas L Mann,

Watch time: 11m 30s
ACC 2021 Discussion: Benefits of SGLT1/2 Inhibition Across the Full Spectrum of EF, Including HFpEF

Deepak L Bhatt, Harriette Van Spall,

Watch time: 16m 6s
ACC 21 Edition of Masterclass: Hostility & Harassment: How to Change Workplace Culture in Cardiology

Harriette Van Spall, Garima Sharma, Laxmi Mehta, et al

Watch time: 17m 58s
ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall,

Watch time: 15m 2s
ACC 21 Discussion: The Randomized Sham-controlled RADIANCE-HTN TRIO Trial

Ajay J Kirtane, Harriette Van Spall,

Watch time: 16m 20s
ACC 2021 Discussion: The Coalition ACTION Trial

Harriette Van Spall, Renato D Lopes,

Watch time: 16m 3s
Masterclass: Smashing the Glass Ceiling

Cindy Grines, Harriette Van Spall,

Watch time: 15m 10s
Masterclass: New Universal Definition and Classification of Heart Failure

Harriette Van Spall, Biykem Bozkurt,

Watch time: 11m 7s
AHA 2020 Discussion: The SCORED Study

Harriette Van Spall, Deepak L Bhatt,

Watch time: 16m 9s
AHA 2020 Discussion: The EPIC-HF Trial

Larry A Allen, Harriette Van Spall,

Watch time: 18m 54s

Articles by Harriette Van Spall, Associate Professor of Medicine, Director of E-Health and Virtual Care

Remote Patient Monitoring for Patients with Heart Failure: Sex- and Race-based Disparities and Opportunities

Ioannis Mastoris, Ersilia M DeFilippis, Trejeeve Martyn, et al

Published:

Citation: Cardiac Failure Review 2023;9:e02.

DOI:

https://doi.org/10.15420/cfr.2022.22
Contemporary Review of Hemodynamic Monitoring in the Critical Care Setting

Aniket S Rali, Amy Butcher, Ryan J Tedford, et al

Published:

Citation: US Cardiology Review 2022;16:e12.

DOI:

https://doi.org/10.15420/usc.2021.34